
News|Articles|May 8, 2024
Long-Acting Injectables: Part 1 of a Conversation With Peter J. Weiden, MD
Author(s)Peter J. Weiden, MD, John J. Miller, MD
Peter J. Weiden, MD, sat down with Psychiatric Times’ Editor-in-Chief at the 2024 Annual Meeting. Here’s Part 1 of their conversation.
Advertisement
CONFERENCE REPORTER
Psychiatric Times Editor-in-Chief, John J. Miller, MD, sat down with his colleague, Peter J. Weiden, MD, of the State University of New York at Stony Brook at the
Dr Weiden is a professor at the State University of New York at Stony Brook.
See more coverage from the 2024 APA Annual Meeting in Psychiatric Times at
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Classic Drug, New Target: Lithium as Disease-Modifying in Alzheimer Dementia
2
Podcast: Managing Co-Occurring Mood and Substance Use Disorders With Michael J. Ostacher, MD, MPH
3
Oral Cannabinoid From MediPharm Shows Significant Reduction in Agitation in Alzheimer Disease and Dementia
4
What's Next for Psychedelics in Psychiatry? COMP360 and Beyond
5








